Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

1) Becoming a green low-cost (Capex and Opex) manufacturer of Fumed Silica using the FUMED SILICA REACTOR, a proprietary ...

Vestel has become the first Turkish company to generate revenue from Standard Essential Patent (SEP) licensing, which covers ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Milestone's NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

SINTX Technologies (SINT) announced the issuance of U.S. Patent No. 12,239,761 by the U.S. Patent and Trademark Office, or USPTO. This newly ...

Unity of invention and double patenting law and practice in Canada can create challenges for patent applicants. For example, ...

The FDA is mired in uncertainty with some staffers losing their jobs over the weekend and more potentially to come, vaccines ...

Silo Pharma (SILO) announced the filing of a provisional patent application with the USPTO for its lead asset SPC-15. Silo currently has ...

From Poké Balls to Mass Effect's dialogue wheels, some ideas are so great the developers feel the need to patent them.

NANO Nuclear Energy filed four new utility patent applications with the U.S. Patent and Trademark Office related to the ...

Well, if you think this is not possible, think twice. Microsoft just published a paper describing a patented AI technology ...